INCYTE CORPORATION Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years
INCYTE CORPORATION (INCY) had Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years of $73.33 million as of 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Expected Amounts › Defined Benefit Plan, Expected Future Benefit Payment
us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter · last filed 2026-02-10
- 2025-12-31: Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years $73.33M.
- 2024-12-31: Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years $56.54M.
- 2023-12-31: Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years $56.01M.
- 2022-12-31: Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years $42.44M.
| Period end | Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years |
|---|---|
| 2025-12-31 | $73.33M 10-K · filed 2026-02-10 |
| 2024-12-31 | $56.54M 10-K · filed 2025-02-10 |
| 2023-12-31 | $56.01M 10-K · filed 2024-02-13 |
| 2022-12-31 | $42.44M 10-K · filed 2023-02-07 |
| 2021-12-31 | $33.81M 10-K · filed 2022-02-08 |
| 2020-12-31 | $22.50M 10-K · filed 2021-02-09 |
| 2019-12-31 | $14.98M 10-K · filed 2020-02-13 |
| 2018-12-31 | $11.79M 10-K · filed 2019-02-14 |
| 2017-12-31 | $10.44M 10-K · filed 2018-02-15 |
| 2016-12-31 | $6.07M 10-K · filed 2017-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |